Xaio-Lian Zhang | Immunology | Best Researcher Award

Published on by Global Academic Awards

Prof. Xaio-Lian Zhang | Immunology | Best Researcher Award

Prof. Xaio-Lian Zhang at Wuhan University, China

Dr. Xiao-Lian Zhang 🎓 is the Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 🧬. A leading expert in infection, glyco-immunity, and vaccine development 💉, she focuses on immune evasion by Mycobacterium tuberculosis and Hepatitis C/B viruses 🦠. With a PhD from HKUST and postdoc at the University of Maryland , she has published 190+ papers in top journals 📚 and holds 46 patents 🧪. A recipient of China’s Outstanding Young Scientist Fund 🌟, her innovative research in intracellular pathogens and glycan-targeted therapies has been globally recognized and ranked in the top 2% by Faculty of 1000 🌍.

Publication Profile📚

Orcid

Academic Background🎓

Dr. Xiao-Lian Zhang 🎓 earned her PhD in Biochemistry from the Hong Kong University of Science and Technology (1993–1997) and completed her postdoctoral training at the University of Maryland, USA  (1997–2001). She is currently the Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 🧬. Her research focuses on infection, glyco-immunity, and vaccine development 💉, especially against Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. With over 190 publications 📚, 46 patents 🧪, and numerous national awards 🌟, her work ranks in the top 2% globally 🌍 for its impact and innovation.

Professional background💼

Dr. Xiao-Lian Zhang 💼 is a Hongyi and Luojia Distinguished Professor at Wuhan University and serves as the Chair of the Immunology Department 🧬. She also leads the Hubei Provincial Key Laboratory of Allergic and Immune-related Diseases 🔬. Her research expertise includes infection, glyco-immunity, immune evasion, and vaccine development 💉, particularly targeting Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. She has led major national programs such as the 973 Program and received the National Outstanding Young Scientist Fund 🌟. With over 190 top-tier publications 📚 and 46 granted patents 🧪, she is recognized globally 🌍 for scientific excellence.

Awards and Honors🏅

Dr. Xiao-Lian Zhang 🏅 has received numerous prestigious awards for her outstanding contributions to biomedical research 🌟. She is a recipient of the National Outstanding Young Scientist Fund 🧬 and was selected for China’s “New Century” National Talent Program . As a Hongyi and Luojia Distinguished Professor, she also leads national-level research projects including the 973 Program and Major Infectious Disease Initiatives 🧪. Her innovative work in infection and glyco-immunity has earned over 190 publications 📚 and global recognition, ranking her among the top 2% of scientists worldwide 🌍 according to Faculty of 1000 🏆.

Research Focus🔬

Dr. Xiao-Lian Zhang 🔬 is a leading researcher in infection and immunity, with a special focus on intracellular pathogens like Mycobacterium tuberculosis and Hepatitis B/C viruses 🦠. Her groundbreaking work explores glyco-immunity, immune evasion mechanisms, and the development of glycan-targeted vaccines, drugs, and diagnostics 💉🧪. She has pioneered novel approaches in immunotherapy and molecular diagnostics, enhancing both understanding and treatment of infectious diseases 🧬. Her research has been published in prestigious journals 📚 and frequently cited in leading reviews, earning her recognition among the top 2% of global scientists 🌍 for impactful, innovative scientific contributions.

Publication Top Notes🌟

🔬 Mycobacterial EST12 activates a RACK1-NLRP3-gasdermin D pyroptosis-IL-1β immune pathway
Year: 2020 | Published in: Science Advances

🧬 Binding of cellular nucleolin with the viral core RNA G-quadruplex structure suppresses HCV replication
Year: 2019 | Published in: Nucleic Acids Research

🧪 Detection of circulating Mycobacterium tuberculosis specific DNA by droplet digital PCR for vaccine evaluation
Year: 2018 | Published in: Emerging Microbes & Infections

💉 A Single ssDNA Aptamer Binding to Mannose-Capped Lipoarabinomannan Enhances Immunoprotection against TB
Year: 2016 | Published in: JACS

🧫 Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4⁺ T Cells and Macrophages
Year: 2015 | Published in: Journal of Immunology

🧬 Aptamer against mannose-capped lipoarabinomannan inhibits Mycobacterium tuberculosis in mice and monkeys
Year: 2014 | Published in: Molecular Therapy

🧪 CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents
Year: 2014 | Published in: Journal of Infection

🧬 Ficolin-2 inhibits HCV infection, Apolipoprotein E3 mediates viral immune escape
Year: 2014 | Published in: Journal of Immunology

Conclusion

Professor Xiao-Lian Zhang is a globally recognized leader in infection biology, immunology, and vaccine research 🧬🦠. With a PhD from HKUST and postdoctoral training at the University of Maryland , she currently holds prestigious positions as Hongyi and Luojia Distinguished Professor and Chair of Immunology at Wuhan University 💼. Her research on glyco-immunity, intracellular pathogens like Mycobacterium tuberculosis and Hepatitis B/C viruses, and glycan-targeted therapies has led to 190+ high-impact publications 📚 and 46 granted patents 🧪. Widely cited and ranked in the top 2% globally 🌍, she has secured major national grants and made transformative contributions to science, making her a highly deserving candidate for the Best Researcher Award 🏆.

Saeid Amiri Zadeh Fard | Immunology and Microbiology | Best Extension Activity Award

Published on by Global Academic Awards

Dr. Saeid Amiri Zadeh Fard | Immunology and Microbiology | Best Extension Activity Award

Dr. Saeid Amiri Zadeh Fard , Shiraz University of Medical Sciences , Iran

Dr. Saeid Amiri Zadeh Fard is a renowned researcher specializing in virology and biomedical engineering. He currently serves as the Principal Investigator at the Gastroenterohepathology Research Center in Iran. With a strong focus on RNA-based therapeutic strategies, his doctoral research centered around developing short hairpin RNA (shRNA) approaches for targeting Human Respiratory Syncytial Virus (HRSV). Dr. Zadeh Fard has vast expertise in viral analysis, including virus isolation, gene cloning, and RNA transfection, which he applies to novel treatments for viral and immunological diseases. He thrives in collaborative research environments, maintaining an impeccable attention to detail and exceptional organizational skills. Dr. Zadeh Fard has contributed significantly to the field through various teaching and reviewing roles and has an extensive publication record in viral genomics, molecular diagnostics, and therapeutic interventions.

Publication Profile

Orcid

Education 🎓

Dr. Saeid Amiri Zadeh Fard earned his Ph.D. in Medical Virology from Shiraz University of Medical Sciences (2018-2023). Prior to this, he completed an M.Sc. in Bacteriology at Shahre-Kord University of Medical Sciences (2016-2018), and a B.Sc. from Shiraz Azad University (2011-2016). He also holds an Associate Degree in Medical Sciences from Bandar Abbas University of Medical Sciences (1995-1998). His strong academic background has laid the foundation for his impressive research career in the fields of viral infections, immune regulation, and therapeutic strategies. With specialized training in RNA-based techniques, Dr. Zadeh Fard has made valuable contributions to the understanding and treatment of respiratory and immune-related diseases. His academic journey has been complemented by his continuous involvement in various educational activities, such as teaching microbiology and medical biotechnology courses.

Experience 🏛️

Dr. Saeid Amiri Zadeh Fard’s career spans over two decades in the biomedical and virology research sectors. Since 2018, he has held the position of Principal Investigator at the Gastroenterohepathology Research Center in Iran, where he has advanced research in viral diseases and immunology. His role involves implementing innovative techniques like viral culture, gene cloning, and RNA transfection. Since 2013, Dr. Zadeh Fard has also been the Research Coordinator at the same center, overseeing multiple research projects, training staff, and ensuring high-quality research outcomes. With extensive experience as a Senior Researcher since 2008, he has applied his knowledge in DNA/RNA extraction, cDNA synthesis, and electrophoresis. His teaching experience dates back to 2005, having mentored students in various laboratory techniques and courses in Medical Biotechnology, Medical Engineering, and Medical Laboratory Science. Dr. Zadeh Fard’s extensive expertise has helped shape both research and educational practices in the biomedical field.

Awards and Honors 🏆

Dr. Saeid Amiri Zadeh Fard has earned recognition for his outstanding contributions to medical virology and biotechnology research. Notably, his research on the therapeutic potential of RNA-based interventions in viral diseases has garnered attention internationally. His innovative work in the application of short hairpin RNA (shRNA) for Human Respiratory Syncytial Virus (HRSV) treatment has been highlighted in prestigious scientific publications. Additionally, his role as a reviewer for the Clinica Chimica Acta journal demonstrates his esteemed position within the research community. He has been awarded multiple research grants and continues to be an influential figure in his field, advancing novel therapeutic solutions. His recognition extends to his work as a mentor, having received positive feedback from students and colleagues alike for his contributions to training the next generation of scientists. Dr. Zadeh Fard has also been acknowledged for his dedication to improving laboratory techniques and research protocols.

Research Focus 🔬

Dr. Saeid Amiri Zadeh Fard’s research primarily focuses on viral infections, immune regulation, and the development of novel therapeutic strategies. His doctoral research concentrated on utilizing short hairpin RNA (shRNA) to target Human Respiratory Syncytial Virus (HRSV) replication, presenting a potential new avenue for antiviral therapies. His work includes a detailed understanding of RNA-based molecular techniques, virus isolation, gene cloning, and cell culture systems for the investigation of viral pathogens. Dr. Zadeh Fard’s research extends to studying immune dysregulation in co-infections, particularly HIV and COVID-19, and evaluating therapeutic interventions for immunological disorders. His ongoing research aims to develop advanced strategies for treating viral diseases, such as RSV, and understanding their impact on immune system function. His expertise in virology and biotechnology continues to drive his exploration of molecular diagnostics, antiviral therapies, and immunological disease mechanisms.

Publication Top Notes

Immune Dysregulation in HIV and COVID‐19 Co‐infection: Therapeutic Implications

Comparison of Characteristics and Outcomes of Hepatitis B and Hepatitis C Patients in the Fars Hepatitis Registry

Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment​

Association of Polymorphism of IL‐17A, IL‐17F, and IL‐6 with Toxoplasma gondii Infection Susceptibility in HIV/AIDS Patients in Shiraz, Southern Iran

Simultaneous Detection and Differentiation of Mycobacterium tuberculosis and Nontuberculous Mycobacteria Coexisting in Patients with Pulmonary Tuberculosis by Single-Tube Multiplex PCR​

Detection of Hepatitis B Virus Genome with Mutations Outside the Major Hydrophilic Region in the Surface Antigen Isolated from Patients with Coexisting HBsAg and Anti-HBs​

Short Hairpin RNA-Mediated Matrix Gene Silencing of Human Respiratory Syncytial Virus as a Potent Antiviral Strategy

Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection​

Sustained Suppression of Fusion Gene-Mediated Human Respiratory Syncytial Virus Load by shRNA-Based Therapeutics​

Predictors of Death in the Liver Transplantation Adult Candidates: An Artificial Neural Networks and Support Vector Machine Hybrid-Based Cohort Study

Conclusion

Dr. Saeid Amiri Zadeh Fard’s passion for both research and educational outreach, along with his efforts to engage and empower the next generation of scientists, exemplifies the essence of the “Best Extension Activity Award.” His extensive teaching experience, combined with his active involvement in research, aligns perfectly with the goals of extending knowledge and fostering collaborative research. His dedication to advancing science through both applied research and education solidifies his position as a deserving candidate for this prestigious award.

Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Published on by Global Academic Awards

Omid Yeganeh | Immunology and Microbiology | Best Scholar Award

Dr Omid Yeganeh, Islamic Azad University, Iran

Dr. Omid Yeganeh is a microbiologist with a Ph.D. in Microbiology from the Islamic Azad University, Tehran, Iran. He also holds an M.Sc. in Microbiology and a B.Sc. in Cellular and Molecular Biology. As a researcher at the Monoclonal Antibody Research Center, Avicenna Research Institute, he specializes in producing monoclonal antibodies against various molecules, including PSA, prolactin, ferritin, and sperm surface antigens. Dr. Yeganeh serves as a technical editor and associate editor for several journals, contributing to the advancement of microbiological research. His work has significantly impacted the field of immunology and antibody development. 🔬🧬💉

Publication profile

google scholar

Education

Dr. Omid Yeganeh holds an impressive academic background, earning a Ph.D. in Microbiology from the Department of Microbiology at the Islamic Azad University, Tehran, Iran. His M.Sc. in Microbiology and B.Sc. in Cellular and Molecular Biology with a focus on Microbiology further enhance his foundational knowledge in the field. As a member of the Monoclonal Antibody Research Center at the Avicenna Research Institute, he is well-versed in cutting-edge research methodologies.

Research Experience

Dr. Yeganeh’s extensive experience as a researcher at the Monoclonal Antibody Research Center showcases his commitment to advancing the field of microbiology and immunology. His role as a technical editor and associate editor for scientific journals highlights his expertise and active participation in academic discourse. His hands-on research experience equips him with a practical understanding of the latest methodologies in microbiology.

Research Activities

His work focuses on the production of monoclonal antibodies against various clinically significant molecules, including PSA, prolactin, and sperm surface antigens. He has successfully produced monoclonal antibodies against over 100 different peptides, showcasing his technical expertise in hybridoma techniques and cell culture. This innovative research has the potential to contribute significantly to diagnostic and therapeutic applications in medicine.

Congress Participation

Dr. Yeganeh actively participates in international congresses, such as the 15th Virtual International Congress of Immunology & Allergy and the ICIA 2023, where he presents his research findings. His engagement in these forums not only broadens his professional network but also enhances the visibility of his research contributions on a global scale.

Research focus

Dr. Omid Yeganeh is a prominent researcher with a focus on medical biotechnology, particularly in immunology and microbiology. His work includes the production and characterization of monoclonal antibodies against various human proteins and pathogens, highlighting his expertise in antibody development for diagnostic and therapeutic applications. He has also investigated infectious diseases, including the emergence of antibiotic-resistant bacteria, contributing to the understanding of microbial drug resistance. His research significantly impacts both clinical diagnostics and therapeutic strategies. 🧬🔬📊

Publication top notes

Intra-and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction …

The Challenge of Global Emergence of Novel Colistin-Resistant Escherichia coli ST131

Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta‐specific 1

A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of Labbafinejad …

Production and characterization of a murine monoclonal antibody against human ferritin

Skull base aneurysmal bone cyst presented with foramen jugular syndrome and multi-osseous involvement

Fibro-osseous lesions of the skull base in the pediatric population

Production and characterization of monoclonal antibodies against human prostate specific antigen

Conclusion

Dr. Omid Yeganeh’s academic credentials, research experience, and extensive publication record make him a highly suitable candidate for the Best Researcher Award. His innovative research in monoclonal antibody production and his commitment to advancing scientific knowledge in microbiology not only demonstrate his capabilities as a researcher but also indicate his potential for future contributions to the field.

 

Hadi Hassannia | Immunology | Best Researcher Award

Published on by Global Academic Awards

Dr. Hadi Hassannia | Immunology | Best Researcher Award

Dr. Hadi Hassannia, Mazandaran University of Medical Sciences, Iran

Dr. Hadi Hassannia is a prominent researcher at the Amol Faculty of Paramedical Sciences and the Immunogenetic Research Center of Mazandaran University of Medical Sciences in Sari, Iran. His research focuses on cancer immunotherapy and vaccine development, with significant publications on tumor inhibition and insulin-producing cells from stem cells. Dr. Hassannia possesses advanced technical skills in genetic engineering, antibody production, and molecular techniques. His experience as a lab technician in diagnostic laboratories has enriched his practical knowledge in various fields, including hematology and immunology. He is committed to advancing cancer research and therapeutic approaches. 🧬🔬💉

 

Publication Profile

Google Scholar

Work Experience

Dr. Hassannia has a robust work history, having served as a lab technician in various diagnostic laboratories in governmental hospitals from 2009 to 2017. His practical experience in clinical settings enriches his research with a real-world perspective, further bridging the gap between laboratory findings and clinical applications.

Technical Skills

Dr. Hassannia possesses a diverse skill set that enhances his research capabilities:

Genetic Engineering: He has significant experience in genetic engineering, including protein manipulation and monoclonal antibody production.

Immunological Techniques: Proficient in advanced immunological techniques such as flow cytometry, Western blotting, and ELISA, he is well-equipped to conduct comprehensive immunological research.

Molecular Techniques: His expertise extends to molecular biology techniques like PCR and gene transfection, which are essential for cancer research and therapeutic development.

Laboratory Animal Handling: His experience with laboratory animals allows him to perform complex experiments, including tumor induction, vital for his research in cancer models.

 

Research Interests

Cancer Vaccine Development: His work in developing cancer vaccines contributes to the growing field of immunotherapy, which seeks to harness the body’s immune system to combat cancer.

Immunotherapy: He is engaged in research focused on immunotherapy approaches for cancer treatment, highlighting his commitment to improving patient outcomes.

Cancer-Related Inflammation: Understanding the role of inflammation in cancer progression is a critical area of his research, as it can lead to new therapeutic targets.

Tumor Metastasis: His interest in tumor metastasis is vital for understanding how cancer spreads and devising strategies to prevent it.

Conclusion

Dr. Hadi Hassannia’s extensive research experience, impressive publication record, and technical skills make him an exceptional candidate for the Best Researcher Award. His contributions to cancer research, particularly in immunotherapy and vaccine development, demonstrate his potential to impact the field significantly and advance medical science.

 

Publication Top Notes

  • CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice – Cited by: 165, Year: 2017 🧬
  • Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles – Cited by: 85, Year: 2016 📉
  • Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine – Cited by: 76, Year: 2020 💉
  • Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway – Cited by: 72, Year: 2019 🚀
  • Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine – Cited by: 67, Year: 2020 ⚔️
  • Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice – Cited by: 67, Year: 2018 🌱
  • Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model – Cited by: 59, Year: 2018 🌼
  • Myeloid-derived suppressor cells in B cell malignancies – Cited by: 59, Year: 2015 🦠
  • FOXP3 and TGF-β gene polymorphisms in allergic rhinitis – Cited by: 54, Year: 2011 🌿
  • Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet‐rich plasma composite nanofibers – Cited by: 53, Year: 2020 🧪

 

Ali Reza Khosravi | Immunology and Microbiology | Best Researcher Award

Published on by Global Academic Awards

Ali Reza Khosravi | Immunology and Microbiology | Best Researcher Award

Prof Dr Ali Reza Khosravi, University of Tehran, Iran

Dr. Ali Reza Khosravi, DVM, MPH, PhD, is a Professor at the University of Tehran, leading its Mycology Research Center. His expertise in medical mycology spans fungal immunology, antifungal drugs, and immunomodulatory agents. Dr. Khosravi has authored several influential books on fungal infections and allergies and is a distinguished member of ISHAM and Iranian societies in immunology and mycology. Recognized with multiple awards, including Iran’s top researcher accolades, he continues to advance fungal immunology globally. 🍄

Publication profile

orcid

Education

Dr. Ali Reza Khosravi holds a diverse academic background. He earned his DVM from the University of Tehran in 1985, focusing on fish skin ulcer caused by Aspergillus species under the guidance of Prof. B. Mokhayer. Dr. Khosravi then pursued an MPH from Tehran University of Medical Sciences in 1988. In 1992, he completed his PhD in Medical Mycology at Tehran University of Medical Sciences, researching dermatophyte antigens and immunity to dermatophytosis under the supervision of Prof. M. Emami and Prof. H. Tadjbakhsh. He further honed his expertise through fellowships in Fungal Immunology at the University of Sao Paolo, Brazil, and Fungal Allergy and Immunology at the University of Leeds, UK. 🍄

Experience

Since 1992, Dr. Ali Reza Khosravi has been dedicated to academia at the University of Tehran, Iran. Starting as an Assistant Professor from 1992 to 1996, he advanced to the position of Associate Professor from 1996 to 2001. Since 2001, he has held the prestigious title of Professor, continuing his impactful research and mentorship at the University. Dr. Khosravi’s career spans over three decades of commitment to mycology research, focusing on fungal immunology, antifungal drugs, and immunomodulatory agents. His contributions have earned him recognition as a leading authority in his field, bolstered by numerous awards and affiliations with international mycological societies. 🎓

Honors

Dr. Ali Reza Khosravi has been recognized with prestigious awards throughout his career, underscoring his exceptional contributions to veterinary and medical mycology. His accolades include the Award of the First Ranked Professor in Iran (2008), the Award of the First Ranked Researchman in Iran (2004), and multiple honors as the top researcher at the University of Tehran (2001, 2004). Dr. Khosravi’s scholarly achievements were also celebrated internationally, with awards for Best Presented Papers at the International Veterinary Congress in Rio De Janeiro, Brazil (1992), and Top Presented Papers at the Asia Pacific International Congress in Penang, Malaysia (2004). 🏆

Research focus

Dr. Ali Reza Khosravi’s research focuses on diverse aspects of medical mycology and fungal immunology, exploring antifungal agents, immunomodulatory therapies, and the susceptibility profiles of fungal pathogens. His contributions span from investigating the chemical compositions of natural compounds against fish fungal infections to evaluating the antifungal potentials of essential oils and their combinations with conventional drugs. Dr. Khosravi’s work is pivotal in understanding fungal diseases’ mechanisms and developing novel therapeutic approaches 🍄.

Publication top notes

Biomimetic functionalized metal organic frameworks as multifunctional agents: Paving the way for cancer vaccine advances

Disseminated protothecosis: Case report and review of the literature

Actinomyces in Hand: An Unusual Cause of Osteomyelitis

Antifungal susceptibility profile of yeasts isolated from the oral cavity of cats

Chemical composition and in vitro antifungal activity of Sambucus ebulus and Actinidia deliciosa on the fish pathogenic fungus, Saprolegnia parasitica

Potential antifungal impact of citral and linalool administered individually or combined with fluconazole against clinical isolates of Candida krusei

Intrinsic Oncolytic Activity of Hoshino Mumps Virus Vaccine Strain Against Human Fibrosarcoma and Cervical Cancer Cell Lines

The efficacy of zymosan in pro-inflammatory cytokine production by peritoneal macrophages of melanoma-bearing mice

Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals.

Chitin-Induced Airway Epithelial Cell Innate Immune Responses Are Inhibited by Carvacrol/Thymol

Saade Jasim | Immunology Award | Best Researcher Award

Published on by Global Academic Awards

Assist Prof Dr. Saade Jasim | Immunology Award | Best Researcher Award

Assist Prof Dr. Saade Jasim, Fallujah university, Iraq

Dr. Saade Jasim is an Iraqi educator and researcher specializing in microbiology. He earned his Ph.D. from Al-Azhar University, Egypt, with expertise in anticancer nanocarriers and therapeutic applications of stem cell-derived vesicles. Dr. Jasim holds a strong academic background from Anbar and Tikrit Universities, focusing on biological sciences. His research, published in reputable journals, highlights his contributions to cancer treatment and autoimmune diseases. Fluent in Arabic and proficient in English, he excels in teamwork, time management, and handling pressure. Dr. Jasim’s technical skills include Microsoft Office and social media management. He resides in Ramadi, Iraq, dedicated to advancing education and scientific innovation. 📚

 

Publication profile

Scopus 

Orcid

Google Scholar

Education

Dr. Saade Jasim, an accomplished Iraqi educator and researcher, was born on February 3rd, 1989, in Ramadi, Al Anbar, Iraq. He pursued his academic journey with a strong foundation in biological sciences, earning his Ph.D. in Microbiology from Al-Azhar University, Egypt, in 2022. Prior to this, he completed a Bachelor’s degree in Microbiology from Tikrit University in 2016 and a degree in Biology from Anbar University in 2012.

 

Research Focus

Dr. Saade Jasim’s research primarily focuses on the synthesis and application of advanced nanomaterials in various biomedical and environmental contexts. 🧬 His notable contributions include the development of magnetic nanocarriers for drug delivery, nanocomposites for catalytic reactions, and novel nanosorbents for environmental remediation. He explores the intersection of nanotechnology with microbiology and biotechnology, aiming to enhance therapeutic strategies and environmental sustainability. Dr. Jasim’s work also encompasses the study of mesenchymal stem cell-derived therapies for autoimmune diseases, underscoring his commitment to advancing both clinical and fundamental aspects of biomedicine. 🌱

 

Publication Top Notes